This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abiomed, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by John Kenneth Ryder in Ventricular Support Technology
Introduction
John Kenneth Ryder is an accomplished inventor based in Danvers, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of ventricular support for patients undergoing high-risk procedures. His innovative approach has the potential to improve patient outcomes during critical interventions.
Latest Patents
Ryder holds a patent for "Methods for providing ventricular support for a human patient." This patent describes a method that involves inserting a mechanical circulatory support device into the vasculature of a human patient. The device is designed to be movable between a compressed state and an expanded state, allowing for effective delivery into the heart with the aid of a delivery assist device. The operation of this device during a support period has been shown to result in a clinically significant arrhythmia adverse event rate of approximately 2.3%.
Career Highlights
John Kenneth Ryder is associated with Abiomed, Inc., a company known for its advancements in heart pump technology. His work at Abiomed has focused on developing innovative solutions that enhance the safety and efficacy of cardiac procedures. Ryder's expertise in mechanical circulatory support devices has positioned him as a key figure in the medical device industry.
Collaborations
Due to space constraints, the details of Ryder's collaborations will not be included in this article.
Conclusion
John Kenneth Ryder's contributions to ventricular support technology exemplify the impact of innovation in the medical field. His patent and work at Abiomed, Inc. highlight the importance of advancements in patient care during high-risk procedures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
